Vaccination

Clinicians could help patients overcome vaccine hesitancy by highlighting the potential harms of not being vaccinated rather than emphasizing the benefits of a vaccine, according to a study published in the Journal of Public Health.

WHO this week announced that cholera cases increased by 13% and cholera deaths increased by 71% globally in 2023.

During their first season in use, respiratory syncytial virus vaccines reduced the risk for RSV-associated hospitalization by 75% among adults aged 60 years or older, according to a study.

Considering the current surge of COVID-19 cases, primary care providers should counsel patients to prepare for this winter’s inevitable spike, according to an expert.

Given the nuances of COVID-19 vaccine protection, Kizzmekia Corbett-Helaire, PhD, an assistant professor of immunology and infectious diseases at Harvard's School of Public Health, said the U.S. “should remain diligent in reviewing efficacy and safety data of each COVID-19 vaccine update to make progressional recommendations.”

The FDA granted emergency use authorization for an updated version of the COVID-19 vaccine manufactured by Novavax that targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2 virus.

CDC advisors this year introduced the idea of transitioning the United States from a universal recommendation for COVID-19 vaccination to a recommendation based on individual risk factors.

A measles outbreak in Oregon has grown to include 30 cases, all of them in unvaccinated people, according to state health officials, who warned about further spread as the school year begins.

Asian American, Native Hawaiian and Pacific Islander, or AA and NH/PI, communities continue to face significant racial disparities in health care access and outcomes across the United States, according to an expert.

Clinical outcomes after COVID-19 vaccine-related myocarditis were similar vs. myocarditis from COVID-19 infection, and events were fewer vs. conventional myocarditis, researcher reported.